Assad dismisses Syria's central bank chief: State news agency    Liverpool's Klopp urges caution against high-flying but depleted Real    CIB's stocks hit lowest level in 28 months early Tuesday    African civil society representatives call for GERD 2nd filling postponement    Nile tensions spill over    Ukraine minister calls for military help, more Russia sanctions    Tennis: Medvedev tests COVID-19 positive, out of Monte Carlo Masters    Women more affected than men by depression: Egyptian Psychiatric Association    Forging a stronger partnership    Live score: Chelsea v FC Porto (UEFA Champions League)    Party consensus    Ramadan and the pandemic in Egypt    Human rights vs coronavirus in Egypt    'MySafeUni Day' highlights fight against sexual harassment in universities    Sisi directs to speed up implementation of digitisation initiative in Egypt    34 projects worth $3.3bn aim to achieve gender equality in Egypt: Al-Mashat    Egypt's trade deficit widens by 6.6% during H1 of FY20/2021, CBE    Opportune time for archaeotourism    Parliament discusses new budget    Ora Developers signs an agreement with Telecom Egypt for communication services at its projects    Sisi greets Egyptians, Muslim, Arab nations on occasion of Ramadan    Art Alert: Bahgaga to bring fun to Cairo's Zamalek Theatre with comedy music monologues    Tatweer Misr signs EGP 3.2bn worth investment contracts for Bloomfields educational zone    Egypt highlights anti-climate change efforts during Spring Meetings    Water wars    Don't miss AUC's Lions of Cairo ensemble concert    Prominent American rapper and actor DMX dies at 50    Al-Sisi, Lavrov address bilateral cooperation, Ethiopia's disputed dam    Narrative Summit launches 1st episode of Reshaping Norms 2021    Russia offers technical assistance in Nile dam negotiation: Lavrov    2021 Copenhagen Documentary Festival to launch Big Digital Live Platform    Egyptian artists honoured at Cairo Opera House for taking part in Golden Parade    Russian FM says Egypt is main partner in Middle East, Africa    Egyptian-African Relations Committee discusses strengthening Egypt's stance in Africa    Egypt will not allow internal water crisis due to Ethiopian dam: Water Minister    Egypt's Public Prosecution announces results of investigations into Sohag train crash    Egypt sees an uptick in new coronavirus infections registers 801 new cases on Saturday    PMI moves towards a smoke-free transformation, takes part in a webinar on e-cigarettes    Zamalek's Shikabala nominated for best goal in CAF Champions League    Egypt's national youth fencing team achieves world glory    Karate Federation celebrates success of Egypt Cup    Egypt's President warns of grave consequences of water crises in Africa    Allianz Egypt partners with IGNITE to equip brand ambassadors for 2021 Olympics    Hassan Allam consortium wins contract to manage, operate Grand Egyptian Museum    Enhanced Labs signs Mr. Olympia 2020 "Big Ramy" And His Trainer Dennis James    King Tutankhamun funerary mask is must-see tourist icon: The Telegraph    Seasoned Egyptian screenwriter Wahid Hamed dies at 76    Egypt, Ethiopia, Sudan to resume Nile dam talks today    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





Sanofi ready to produce over 600 million coronavirus vaccine doses if proven successful
Published in Amwal Al Ghad on 18 - 04 - 2020

French drugmaker Sanofi is ready to produce up to 600 million doses of its coronavirus vaccine next year if its clinical trials with GlaxoSmithKline go as planned, its chief executive Paul Hudson said on Friday.
"We believe we're one of the few companies who will be able to make a vaccine at a huge scale," Hudson said in an interview with CNBC.
On Tuesday, Sanofi and GlaxoSmithKline announced a historic partnership to jointly create a vaccine by the end of 2021.
The two pharma giants are planning to start clinical trials in the second half of 2020 and, if successful, make it available to the public by the second half of 2021.
Sanofi and GlaxoSmithKline are one of several companies working on a potential vaccine for coronavirus.
To date, there is no approved drug for coronavirus disease, and drugmakers are racing to produce a vaccine, which is expected to take 12 to 18 months.


Clic here to read the story from its source.